Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
18
Recruiting, any sponsor type, condition "uterine fibroids"
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed107
18 trials
Showing 1 to 18, recently updated first.
Christiana Care Health ServicesAcademic, hospital or other
NCT07664956 · 36 participants (planned) · Start Sep 1, 2026 · Primary completion May 1, 2027
Drug: Cyclobenzaprine · For: Minimally Invasive Surgical Procedures; Abnormal Uterine Bleeding, Unspecified; Adenomyosis of Uterus and 6 more
Sites: Newark, Delaware
- Prescription of Letrozole for Uterine MyomaPivotal-lookingRecruiting
University of California, San FranciscoAcademic, hospital or other
NCT06143631 · 140 participants (planned) · Start Jul 24, 2024 · Primary completion Sep 11, 2028
Drug: Letrozole 2.5mg · For: Leiomyoma, Uterine; Leiomyoma; Fibroid and 1 more
Sites: Los Angeles, California; San Francisco, California; Rochester, Minnesota · 5 sites in all
- Stellate Ganglion Block and Dexmedetomidine for Postoperative Sleep in Women Undergoing Laparoscopic Gynecologic SurgeryPivotal-lookingRecruiting
Catherin ZhangAcademic, hospital or other
NCT07860203 · 100 participants (planned) · Start Oct 2026 · Primary completion Dec 2026
Drug: DEX 0.2 μg/kg/h.; 0.9% Sodium Chloride (Placebo) · For: Uterine Fibroids (Leiomyoma); Adenomyosis of Uterus; Endometriosis and 3 more
Sites: Huai'an, China
- QL Block in Laparoscopic MyomectomyRecruiting
Joseph Findley MDAcademic, hospital or other
NCT05979493 · 80 participants (planned) · Start Aug 24, 2024 · Primary completion Jul 1, 2028
Drug: Bupivacain; Saline · For: Postoperative Pain; Fibroid Uterus
Sites: Beachwood, Ohio
- Deep Neuromuscular Blockade and a Low-Residue Diet for the Surgical Field in vNOTES HysterectomyPivotal-lookingRecruiting
Fatih Sultan Mehmet Training and Research HospitalAcademic, hospital or other
NCT07730970 · 160 participants (planned) · Start Jul 1, 2026 · Primary completion Jul 25, 2027
Drug: Deep Neuromuscular Blockade (NMB); Standard (moderate) neuromuscular blockade · For: Leiomyoma, Uterine; Benign Gynecological Disease; Abnormal Uterine Bleeding (AUB) and 2 more
Sites: Istanbul, Turkey (Türkiye); Kütahya, Turkey (Türkiye) · 3 sites in all
Northwestern UniversityAcademic, hospital or other
NCT07286188 · 40 participants (planned) · Start Dec 16, 2025 · Primary completion Dec 2026
Drug: Misoprostol Tabets; Placebo · For: Fibroids, Uterine; Fluid Deficit; Hysteroscopy / Methods
Sites: Chicago, Illinois
- to Evaluate the Efficacy and Safety of KLH-2109 in Patients With Uterine Fibroids and MenorrhagiaPivotal-lookingRecruiting
JW PharmaceuticalIndustry
NCT07378098 · 254 participants (planned) · Start Feb 3, 2026 · Primary completion Mar 31, 2028
Drug: KLH-2109+ Leurprorelin acetate Placebo; KLH-2109 Placebo + Leurprorelin acetate · For: Menorrhagia; Uterine Fibroids
Sites: Seoul, South Korea
University Hospital, GenevaAcademic, hospital or other
NCT07173127 · 30 participants (planned) · Start Sep 30, 2025 · Primary completion Dec 30, 2026
Drug: Ryeqo treatment · For: Uterine Fibroid
Sites: Geneva, Switzerland
- TEAS Combined With Triple Antiemetic Drugs to Prevent PONV in High-Risk PatientsPivotal-lookingRecruiting
Zhejiang UniversityAcademic, hospital or other
NCT07480785 · 780 participants (planned) · Start Jan 16, 2026 · Primary completion Oct 31, 2027
Drug: triple antiemetic drugs · For: Uterine Fibroids (Leiomyoma); Ovarian Tumors; Gallstones
Sites: Hangzhou, China
- Phase II Study of CMS-D002 Capsule for Uterine Fibroids With MenorrhagiaPivotal-lookingRecruiting
Shenzhen Kangzhe Biotechnology Co., Ltd.Industry
NCT07402369 · 120 participants (planned) · Start Feb 19, 2026 · Primary completion Jan 3, 2027
Drug: CMS-D002 Capsules 10 mg; CMS-D002 Capsules 25 mg and 2 more · For: Uterine Fibroids With Menorrhagia
Sites: Beijing, China
Cairo UniversityAcademic, hospital or other
NCT07390864 · 40 participants (planned) · Start Jan 18, 2026 · Primary completion Jul 30, 2026
Drug: Methylergometrine (Intramyometrial Injection); Carbetocin (Intramyometrial Injection) · For: Myoma;Uterus
Sites: Al Fayyum, Egypt
- Efficacy & Safety Study of Relugolix in Women With Heavy Menstrual Bleeding Associated With Uterine FibroidsPivotal-lookingRecruiting
Qilu Pharmaceutical Co., Ltd.Industry
NCT06671548 · 120 participants (planned) · Start Jan 15, 2024 · Primary completion Nov 12, 2026
Drug: Relugolix; Relugolix placebo · For: Heavy Menstrual Bleeding; Uterine Fibroids
Sites: Beijing, China
- The Effects of One-time Intraoperative Methadone During Laparoscopic Hysterectomy in Reducing Opioid Prescription.Pivotal-lookingRecruiting
Johns Hopkins UniversityAcademic, hospital or other
NCT06536517 · 100 participants (planned) · Start Mar 7, 2025 · Primary completion Dec 2026
Drug: Methadone · For: Fibroid Uterus
Sites: Baltimore, Maryland · 2 sites in all
Sumitomo Pharma Switzerland GmbHIndustry
NCT05739123 · 728 participants (planned) · Start May 8, 2023 · Primary completion May 2033
Drug: Relugolix-Containing Product · For: Pregnancy Related; Pregnancy Complications; Pregnancy, High Risk
Sites: Wilmington, North Carolina
Fondazione Policlinico Universitario Agostino Gemelli IRCCSAcademic, hospital or other
NCT06953076 · 111 participants (planned) · Start May 2, 2025 · Primary completion May 2, 2026
Drug: Relugolix/estradiol/norethisterone acetate · For: Uterine Bleeding; Uterine Leiomyomas; Uterine Hemorrhage and 1 more
Sites: Roma, Italy
- A Phase 3B Study to Evaluate Bone Mineral Density With Long-Term Use of Relugolix Combination Tablet in Women With Uterine Fibroids or EndometriosisPivotal-lookingRecruiting
Sumitomo Pharma Switzerland GmbHIndustry
NCT05862272 · 1,000 participants (planned) · Start Aug 14, 2023 · Primary completion Jul 2029
Drug: Relugolix Combination Tablet · For: Uterine Fibroids; Endometriosis
Sites: Mobile, Alabama; Chandler, Arizona; Mesa, Arizona · 120 sites in all
Nahida AkterAcademic, hospital or other
NCT07012161 · 39 participants (planned) · Start Feb 20, 2025 · Primary completion Sep 2026
Drug: Colecalciferol (Vitamin D3) 50000 UI · For: Symptomatic Uterine Fibroid
Sites: Dhaka, Bangladesh · 2 sites in all
Thomas Jefferson UniversityAcademic, hospital or other
NCT06705075 · 80 participants (planned) · Start Jan 27, 2025 · Primary completion Aug 31, 2026
Drug: Perfluten · For: Uterine Fibroid
Sites: Philadelphia, Pennsylvania
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.